Integrum AB (publ) (INTEG_B) Q2 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Integrum Ab Class B.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.702 -- 00:00:06.367 Hello, and welcome to today's presentation, where we have Integrum presenting their Q2 00:00:06.367 -- 00:00:11.592 report. With us presenting, we have Acting CEO, Scott Flora, and CFO, 00:00:11.592 -- 00:00:16.276 Juergen Svonström. If you have any questions, please use the form located to the right, 00:00:16.276 -- 00:00:20.080 and we'll take that up during the Q&A after the presentation. 00:00:20.080 -- 00:00:24.242 And with that said, please go ahead with your presentation. 00:00:31.151 -- 00:00:33.586 Juergen? Yeah, 00:00:33.586 -- 00:00:38.913 here we can see the agenda for today. We will have a brief introduction 00:00:38.913 -- 00:00:44.842 from Scott and then a business update. And myself, I will do a financial update. 00:00:44.842 -- 00:00:51.552 And after that, a summary and some Q&A at the end. 00:00:51.552 -- 00:00:54.076 So with that said, over to you, Scott. 00:00:54.076 -- 00:00:59.161 Thanks. Thanks, Jorgen, and good morning. if you're here in the East Coast 00:00:59.161 -- 00:01:04.024 US and good afternoon to all of you in Sweden. 00:01:04.227 -- 00:01:10.373 And I'm very happy to present this Q2 report today and spend a little more time on 00:01:10.373 -- 00:01:14.578 what we think are the critical things the company needs to do. 00:01:14.578 -- 00:01:16.460 First, 00:01:16.460 -- 00:01:18.182 why 00:01:18.182 -- 00:01:20.404 do I get involved with Integra and why am I here? 00:01:20.404 -- 00:01:25.469 This is a phenomenal product. If you look at the orthopedic marketplace, 00:01:25.469 -- 00:01:30.565 hasn't been a lot of true innovation and a lot of PMAs that have been done that really 00:01:30.565 -- 00:01:35.671 impact patients lives the way we do. And, and therefore I think 00:01:35.671 -- 00:01:40.817 thi...